Odisha govt orders probe into 'spurious' COVID-19 medicines in Bhubaneswar, 5 other districts
FirstpostOfficials said that ‘spurious’ tablets of Favipiravir were seized in Bolangir, Jharsuguda, Sambalpur, Rourkela and Bhubaneswar districts on 11 June Bhubaneswar: The Odisha government on Saturday ordered a probe into the alleged circulation of ‘fake’ COVID-19 medicines, officials said. The government also decided to initiate legal action against those responsible for supplying “spurious COVID-19 medicines” seized in the last two days, they said. Acting on a tip-off from the Food and Drugs Administration, Maharashtra on spurious Favipiravir tablets allegedly manufactured by a company in Himachal Pradesh, the authorities in Odisha initiated actions. The inspectors also found the manufacturer of the medicine was a non-existing entity, he said, adding that during the raid, it was noted that the Cuttack-based company had purchased 58,000 “Favimax-400” tablets from an entity located at Gautam Budh Nagar in Uttar Pradesh.
History of this topic
Parliamentary panel to review apex drug regulator’s performance on stopping spurious drugs
Live Mint
‘Spurious’ drugs worth around ₹6.60 crore seized in Kolkata
The Hindu
Are Pharmaceutical Companies Indulging in Illegal Activities To 'Spread' Viral Diseases? Madras High Court Seeks Report From State
Live Law
Crime Branch to probe spurious Covid drugs case after seizure from different districts in Odisha
India Today
Mumbai: Man held for making fake Covid drugs at private lab in UP's Meerut
India Today
Ayurveda Covid medicine given at Krishnapatnam under scanner
Deccan Chronicle
Delhi High Court Asks Delhi Police To File Report In Plea Seeking Action Against Politicians Hoarding, Illegally Distributing Covid Medicines
Live Law
Gujarat High Court Issues Notices Over BJP's Remdesivir Distribution Drive
Live Law
Coronavirus | Supreme Court to seek government response on plea on COVID-19 drugs
The HinduDiscover Related